Exact Mass: 308.1862
Exact Mass Matches: 308.1862
Found 127 metabolites which its exact mass value is equals to given mass value 308.1862,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tetraphyllicine
2-(3,7-Dimethyl-2,6-octadienyl)-3-methyl-1,4-naphthoquinone
2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-methylnaphthalene-1,4-dione
(R)-1-O-b-D-glucopyranosyl-1,3-octanediol
(R)-1-O-b-D-glucopyranosyl-1,3-octanediol is found in pomes. (R)-1-O-b-D-glucopyranosyl-1,3-octanediol is a constituent of apples Constituent of apples. (R)-1-O-b-D-glucopyranosyl-1,3-octanediol is found in pomes.
Gestrinone
Gestrinone was developed in the early 1970s and was tested clinically as a weekly oral contraceptive in European and North American countries. ]. Without significant advantages over other oral contraceptives and with its high price, gestrinone was no longer used after the Stage II clinical trial. However, from 1982 aroused widespread interest due to substantial therapeutic effects in treating endometriosis. Under different endocrine conditions, gestrinone possesses estrogenic, progestational, androgenic, antiestrogenic and antiprogesterone actions. Starting from gestrinone, chemists can synthesize tetrahydrogestrinone (THG) in one reaction step. THG is a real designer steroid; designer steroids (chemically modified steroids) pose a threat to the integrity of the sport community. These compounds have recently been detected in urine specimens from athletes, resulting in temporary or permanent suspension from amateur and/or professional competition. (PMID: 15934041, 17707720) [HMDB] Gestrinone was developed in the early 1970s and was tested clinically as a weekly oral contraceptive in European and North American countries. ]. Without significant advantages over other oral contraceptives and with its high price, gestrinone was no longer used after the Stage II clinical trial. However, from 1982 aroused widespread interest due to substantial therapeutic effects in treating endometriosis. Under different endocrine conditions, gestrinone possesses estrogenic, progestational, androgenic, antiestrogenic and antiprogesterone actions. Starting from gestrinone, chemists can synthesize tetrahydrogestrinone (THG) in one reaction step. THG is a real designer steroid; designer steroids (chemically modified steroids) pose a threat to the integrity of the sport community. These compounds have recently been detected in urine specimens from athletes, resulting in temporary or permanent suspension from amateur and/or professional competition. (PMID: 15934041, 17707720). G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XA - Antigonadotropins and similar agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Indecainide
Indecainide is only found in individuals that have used or taken this drug. It is a rarely used antidysrhythmic. Indecainide has local anesthetic activity and belongs to the membrane stabilizing (Class 1) group of antiarrhythmic agents; it has electrophysiologic effects characteristic of the IC class of antiarrhythmics.Indecainide acts on sodium channels on the neuronal cell membrane, limiting the spread of seizure activity and reducing seizure propagation. The antiarrhythmic actions are mediated through effects on sodium channels in Purkinje fibers. C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent
3-(1-methyl-piperidin-2-yl)-3,4-dihydro-2H-benzo[c]pyrido[1,2-a]azepin-6-one
(+/-)-nitraraine|(-)-nitraraine|Alloyohimb-16-en-16-methanol|Nitraraine|yohimb-16-en-16-yl-methanol
N(1)-methyl-14,15-didehydro-12-hydroxyaspidofractinine
(+)-(4aS,12bS)-4,4,12b-trimethyl-1,2,3,4,4a,5,6,12b-octahydrobenzo[a]anthracene-8,11-dione|(+)-cyclozonarone|Cyclozonarone
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based on: CCMSLIB00000845933]
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based: Match]
2-Pyrrolidinone, 4-(2-aminoethyl)-1-ethyl-3,3-diphenyl- (AHR 5904)
Gestrinone
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XA - Antigonadotropins and similar agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Indecainide
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent
(R)-1-O-b-D-glucopyranosyl-1,3-octanediol
2-Methoxycarbonyl-1-phenylethylboronic acid pinacol ester
1-BOC-2-[(4-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-3-[(2-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-3-[(3-FLUOROBENZYL-AMINO)-METHYL]-PYRROLIDINE
1-BOC-3-[(3-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-3-[(4-FLUOROBENZYL-AMINO)-METHYL]-PYRROLIDINE
1-BOC-3-[(4-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
2′-(Di-tert-butylphosphino)acetophenone ethylene ketal
tert-butyl 4-(aminomethyl)-4-(4-fluorophenyl)piperidine-1-carboxylate
1-BENZYL-4,5-DIHYDRO-3H-SPIRO[BENZO[B][1,4]OXAZEPINE-2,4-PIPERIDINE]
methyl 3,3-dimethoxy-2-oxa-7,10-diaza-3-silatridecan-13-oate
1-BOC-3-[(2-FLUOROBENZYL-AMINO)-METHYL]-PYRROLIDINE
1-BOC-2-[(2-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-2-[(3-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
tert-Butyl 4-(benzylamino)-3-fluoropiperidine-1-carboxylate
[3-Carboxy-2-(4-phenylbutanoyloxy)propyl]-trimethylazanium
(8S,13S,14R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2-[4-(2-Trimethylsilyloxy-2-methylpropyl)phenyl]propanoic acid methyl ester
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol
(1R,9R,10S,12R,13E,16S,18R)-13-ethylidene-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-trien-18-ol
(1s,14r,19r)-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicosa-2(10),4,6,8,17-pentaen-17-ylmethanol
(1r,12s,15s,17s)-1,14,14-trimethyl-3,13-diazapentacyclo[13.2.2.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]nonadeca-2(10),4,6,8-tetraen-11-one
(4as,12bs)-4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione
(2s,3r,12br)-3-ethenyl-2-[(1e)-2-methoxyethenyl]-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine
3-ethenyl-2-(2-methoxyethenyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine
4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione
(2r,3r,4s,5s,6r)-2-{[(3r)-3-ethyl-4-hydroxy-4-methylpentyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
10-methyl-5-pentyl-13-(prop-1-en-2-yl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-ol
affinisine
{"Ingredient_id": "HBIN014774","Ingredient_name": "affinisine","Alias": "NA","Ingredient_formula": "C20H24N2O","Ingredient_Smile": "CC=C1CN2C3CC1C(C2CC4=C3N(C5=CC=CC=C45)C)CO","Ingredient_weight": "308.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "669","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101286222","DrugBank_id": "NA"}
